Gliomas, which represent the second leading cause of cancer death in individuals under age 35 and the fourth leading cause in those over age 54, are a significant medical problem. To date, the ...

Opportunities include next-generation mRNA, viral vector and DNA platforms; needle-free, oral and nasal delivery; expanded ...

Discover how connecting make and test workflows can accelerate drug discovery by improving decision-making across the DMTA ...

The U.S. Life Science Tools Market is projected to grow from USD 68.50 Billion in 2025 to USD 189.48 Billion by 2035, while ...

This article explores how biobanks, proteomics, and AI are enabling population-scale insights, earlier disease detection, and ...

How do you know what’s coming next, especially with a topic as fast-moving as technology? One way is to focus on the technology itself, as we do every year with our 10 Breakthrough Technologies ...

Generative artificial intelligence (GenAI) tools are challenging our understanding of plagiarism. How should we deal with plagiarism of ideas if this misbehaviour is increasingly common, and it is ...

Background Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers due to its aggressive biology and ...